ROCKVILLE, Md. – Sept. 14, 2026 – Complimentary press passes are now available for the Association for Molecular Pathology 2026 Annual Meeting & Expo , which will be held Nov. 10–14 in Seattle.
AMP’s more than 3,000 members practice in various disciplines of molecular diagnostics, including infectious diseases, inherited conditions, oncology and bioinformatics. AMP 2026 is a five-day event featuring more than 200 exhibiting companies, 60 educational sessions, more than 500 poster presentations, corporate-sponsored workshops and plenary sessions focusing on major areas of clinical molecular diagnostics.
Explore what’s on the horizon of precision medicine and connect with leading experts presenting on such topics as:
Prenatal genetic sequencing
Molecular profiling in pediatric and adolescent young adult tumors
Molecular viral diagnostics for the immunocompromised host
Targeted therapy resistance in acute myeloid leukemia
DNA methylation and AI for the diagnosis and classification of central nervous system tumors
Transcriptomics in lymphomas and leukemias
Single-molecule protein sequencing using nanopores
Transforming healthcare using deep data and remote monitoring
Qualifying writers and editors at print, online and broadcast news media outlets will receive:
Access to all open meeting sessions
Access to embargoed news that will be presented at the meeting
Assistance securing interviews with sources by phone, Zoom and in person
Applicants must provide their media credentials and/or a letter of assignment to register and must bring qualifying identification upon arrival if attending in person.
To register for a press pass to attend AMP 2026 in Seattle or access press materials electronically, please review these media guidelines and contact Andy Noble at anoble@amp.org . Please note that only a limited number of on-site passes will be issued.
For more information about the AMP 2026 Annual Meeting, please visit www.amp26.amp.org .
About AMP
Association for Molecular Pathology was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP’s more than 3,100 members practice various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions and oncology. Our members are pathologists, clinical laboratory directors, basic and translational scientists, technologists and trainees who practice in a variety of settings, including academic and community medical centers, government and industry. Through the efforts of its Board of Directors, Committees, Working Groups and Members, AMP is the primary resource for expertise, education and collaboration in one of the fastest-growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high-quality, appropriate testing. For more information, visit www.amp.org .